![Jack Higgins](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Jack Higgins
Chief Tech/Sci/R&D Officer at
IMMUNOME, INC.
Net worth: 545 750 $ as of 2026-05-30
Profile
Jack Higgins currently works at Immunome, Inc., as Chief Scientific Officer from 2023.
Dr. Higgins also formerly worked at Molecular Templates, Inc., as Chief Development Sciences Officer, Molecular Templates, Inc., as Chief Development Sciences Officer from 2019 to 2021, and MorphImmune, Inc., as Chief Scientific Officer from 2022 to 2023.
Dr. Higgins received his undergraduate degree from Texas A&M University and graduate degree and doctorate degree from The University of Arkansas.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
IMMUNOME, INC. 0.02% | 2026-04-01 | 25,000 ( 0.02% ) | 545 750 $ | 2026-05-30 |
Jack Higgins active positions
| Companies | Position | Start |
|---|---|---|
| IMMUNOME, INC. | Chief Tech/Sci/R&D Officer | 2023-10-01 |
Former positions of Jack Higgins
| Companies | Position | End |
|---|---|---|
MorphImmune, Inc.
 MorphImmune, Inc. BiotechnologyHealth Technology Operates as a biotechnology company focused on developing oncology therapeutics | Chief Tech/Sci/R&D Officer | 2023-09-30 |
Molecular Templates, Inc. /Old/
 Molecular Templates, Inc. /Old/ BiotechnologyHealth Technology Discovers and develops immunotoxins for the treatment of cancer | Chief Operating Officer | 2019-05-31 |
| MOLECULAR TEMPLATES, INC. | Chief Tech/Sci/R&D Officer | - |
Training of Jack Higgins
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
8
1st degree connections
6
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 6 |
|---|---|
Immunome, Inc.
 Immunome, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company which discovers, develops and commercializes antibody therapeutics | Health Technology |
Texas A&M University
 Texas A&M University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The University of Arkansas
 The University of Arkansas Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Molecular Templates, Inc. /Old/
Molecular Templates, Inc. /Old/ BiotechnologyHealth Technology Discovers and develops immunotoxins for the treatment of cancer | Health Technology |
Molecular Templates, Inc.
 Molecular Templates, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a clinical-stage biopharmaceutical company | Commercial Services |
MorphImmune, Inc.
MorphImmune, Inc. BiotechnologyHealth Technology Operates as a biotechnology company focused on developing oncology therapeutics | Health Technology |
- Stock Market
- Insiders
- Jack Higgins
